Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Goulder

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Science (New York, N.Y.)|April 6, 2013
Influence of HLA-C expression level on HIV controlRichard Apps, Ying Qi, Jonathan M Carlson, et al.
Nature|February 27, 2009
Adaptation of HIV-1 to human leukocyte antigen class IYuka Kawashima, Katja Pfafferott, John Frater, et al.
The Lancet. HIV|March 20, 2019
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meetingBoris Julg, Lynda Dee, Jintanat Ananworanich, et al.
The Lancet. Microbe|November 15, 2021
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort studyAdrienn Angyal, Stephanie Longet, Shona C Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2022
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency VirusSarah Fidler, Julie Fox, Timothy Tipoe, et al.
JCI Insight|February 22, 2022
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIVAne Ogbe, Matthew Pace, Mustapha Bittaye, et al.
The Lancet. HIV|June 21, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trialJohn Frater, Katie J Ewer, Ane Ogbe, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Broad and strong memory CD4 <sup>+</sup> and CD8 <sup>+</sup> T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patientsYanchun Peng, Alexander J Mentzer, Guihai Liu, et al.
Nature Communications|April 7, 2021
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responsesAne Ogbe, Barbara Kronsteiner, Donal T Skelly, et al.
Nature Communications|March 11, 2022
Divergent trajectories of antiviral memory after SARS-CoV-2 infectionAdriana Tomic, Donal T Skelly, Ane Ogbe, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Science (New York, N.Y.)|April 6, 2013
Influence of HLA-C expression level on HIV controlRichard Apps, Ying Qi, Jonathan M Carlson, et al.
Nature|February 27, 2009
Adaptation of HIV-1 to human leukocyte antigen class IYuka Kawashima, Katja Pfafferott, John Frater, et al.
The Lancet. HIV|March 20, 2019
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meetingBoris Julg, Lynda Dee, Jintanat Ananworanich, et al.
The Lancet. Microbe|November 15, 2021
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort studyAdrienn Angyal, Stephanie Longet, Shona C Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2022
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency VirusSarah Fidler, Julie Fox, Timothy Tipoe, et al.
JCI Insight|February 22, 2022
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIVAne Ogbe, Matthew Pace, Mustapha Bittaye, et al.
The Lancet. HIV|June 21, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trialJohn Frater, Katie J Ewer, Ane Ogbe, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Broad and strong memory CD4 <sup>+</sup> and CD8 <sup>+</sup> T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patientsYanchun Peng, Alexander J Mentzer, Guihai Liu, et al.
Nature Communications|April 7, 2021
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responsesAne Ogbe, Barbara Kronsteiner, Donal T Skelly, et al.
Nature Communications|March 11, 2022
Divergent trajectories of antiviral memory after SARS-CoV-2 infectionAdriana Tomic, Donal T Skelly, Ane Ogbe, et al.
Pageof 12